Differential effects of some antibiotics on paraoxonase enzyme activity on human hepatoma cells (HepG2) in vitro

References

• Durringhton PN, Mackness B, Mackness MJ. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:473–480
   PubMed Web of Science ®Google Scholar
• Primo Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996;33:498–507.
   PubMed Web of Science ®Google Scholar
• La Du BN, Aviram N, Billecke S, Navab M, Primo-Parmo S, Sorenson RC, Standiford TJ. On the physiological role(s) of the paraoxonases. Chem Biol Interact 1999;119–120: 379–388.
   PubMed Web of Science ®Google Scholar
• Mochizuki H, Scherer SW, Xi T, Nickle DJ, Majer M, Huizenga JJ, Tsui LC, Prochazka M. Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. Gene 1998;213:149–157.
   PubMed Web of Science ®Google Scholar
• Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 1996;14:334–336.
   PubMed Web of Science ®Google Scholar
• Aldridge WN. Serum esterases.II. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera. Biochem J 1953;53:117–124.
   PubMed Web of Science ®Google Scholar
• Billecke S, Draganov D, Counsell R, Stetson P, Watson C, Hsu C, La Du BN. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos 2000;28:1335–1342.
   PubMed Web of Science ®Google Scholar
• Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J Biol Chem 2000;275:3957–3962.
   PubMed Web of Science ®Google Scholar
• Sinan S, Kockar F, Gencer N, Yildirim H, Arslan O. Amphenicol and macrolide derived antibiotics inhibit paraoxonase enzyme activity in human serum and human hepatoma Cells (HepG2) in vitro. Biochemistry (Moscow) 2006;71:46–50.
   PubMed Web of Science ®Google Scholar
• Sinan S, Kockar F, Gencer N, Yildirim H, Arslan O. Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo. Biol Pharm Bull 2006;29:1559–1563.
   PubMed Web of Science ®Google Scholar
• Sinan S, Kockar F, Arslan O. Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics. Biochimie 2006;88:565–574.
   PubMed Web of Science ®Google Scholar
• Farag SA. Simultaneous liquid chromatographic analysis of the beta_lactam antibiotics cefazolin, cefadroxil, cepalexin, ampicillin, and cephradine in solution. J AOAC Int 1998;81:381–385.
   PubMed Web of Science ®Google Scholar
• Sen S, Jaiswal AK, Yanpallewar S, Acharya SB. Anxiogenic potential of ciprofloxacin and norfloxacin in rats. Singapore Med J 2007;48:1028.
   PubMedGoogle Scholar
• Yu H, Yao Y, Liu Y, Jiao R, Jiang W, Zhao GP. A complex role of Amycolatopsis mediterranei GlnR in nitrogen metabolism and related antibiotics production. Arch Microbiol 2007;188:89–96.
   PubMed Web of Science ®Google Scholar
• Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991;19:100–106.
   PubMed Web of Science ®Google Scholar
• Foka P, Irvine SA, Kockar F, Ramji DP. Interleukin-6 represses the transcription of the CCAAT/enhancer binding protein-alpha gene in hepatoma cells by inhibiting its ability to autoactivate the proximal promoter region. Nucleic Acids Res 2003;31:6722–6732.
   PubMed Web of Science ®Google Scholar
• Bergheanu SC, Van Tol A, Dallinga-Thie GM, Liem A, Dunselman PH, Van der Bom JG, Jukema JW. Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol. Curr Med Res Opin 2007;23:2235–2240.
   PubMed Web of Science ®Google Scholar
• Tougou K, Nakamura A, Watanabe S, Okuyama Y, Morino A. Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent. Drug Metab Dispos 1998;26:355–359.
   PubMed Web of Science ®Google Scholar
• Bolayirli IM, Aslan M, Balci H, Altug T, Hacibekiroglu M, Seven A. Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine. Life Sciences 2007;81:121–127.
   PubMed Web of Science ®Google Scholar
• Malin R, Laaksonen R, Knuuti J, Janatuinen T, Vesalainen R, Nuutila P, Lehtimäki T. Paraoxonase genotype modifies the effect of pravastatin on high-density lipoprotein cholesterol. Pharmacogenetics 2001;11:625–633.
   PubMedGoogle Scholar
• Kiranoglu S, Sinan S, Gencer N, Kockar F, Arslan O. In Vivo effects of oral contraceptives on paraoxonase, catalase and carbonic anhydrase enzyme activities on mouse. Biol Pharm Bull 2007;30:1048–1051.
   PubMed Web of Science ®Google Scholar
• Tomas M, Senti M, Garcia-Faria F, Vila J, Torrents A, Covas M, Marrugat J. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2000;20:2113–2119.
   PubMed Web of Science ®Google Scholar
• Leviev I, James R. Simvastatin increases plasma levels of the antioxidant enzyme paraoxonase by PON1 gene activation. Atherosclerosis 2000;151:41.
   Google Scholar
• Gouedard C, Koum-Besson N, Barouki R, Morel Y. Opposite regulation of the human paraoxonase-1 gene PON1 by fenofibrate and statins. Mol Pharmacol 2003;63:945.
   PubMed Web of Science ®Google Scholar
• Aviram M, Billecke S, Sorenson R, Bisgaier C, Newton R, Rosenblat M, Erogul J, Hsu C, Dunlop C, La Du BN. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities. Selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol 1998;18:1617.
   PubMed Web of Science ®Google Scholar